GS-0938
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-0938, covering 2014-02-06 to 2014-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection [Phase 2]